Frontier Capital Management’s Transmedics TMDX Stock Holding History

Frontier Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.97M	Sell	150,162 -170,309	-53%	-$14.4M	0.09%	249
2026 Q1	$31.9M	Buy	320,471 +17,711	+6%	+$2.31M	0.33%	119
2025 Q4	$36.8M	Buy	302,760 +83,294	+38%	+$10.5M	0.39%	84
2025 Q3	$24.6M	Buy	219,466 +146,069	+199%	+$17.1M	0.22%	167
2025 Q2	$9.84M	Sell	73,397 -61,203	-45%	-$6.72M	0.09%	243
2025 Q1	$9.06M	Sell	134,600 -16,410	-11%	-$1.13M	0.1%	227
2024 Q4	$9.42M	Buy	+151,010	New	+$14.1M	0.09%	222

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Frontier Capital Management's TMDX Position: Q2 2026 in Review

Frontier Capital Management reduced its Transmedics (TMDX) stake by 53% in Q2 2026, selling an estimated $14.4M and leaving 150,162 shares worth $9.97M. The position accounts for 0.09% of the portfolio, ranked #249.

Frontier Capital Management first reported a position in TMDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $36.8M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Frontier Capital Management held 150,162 shares of Transmedics worth $9.97M as of Q2 2026.
Frontier Capital Management sold 170,309 Transmedics shares in Q2 2026, an estimated $14.4M.
Transmedics made up 0.09% of Frontier Capital Management's portfolio in Q2 2026, its #249 holding.
Frontier Capital Management first reported a position in Transmedics in Q4 2024 and has held it in 7 quarters since.
Frontier Capital Management's Transmedics position peaked at $36.8M in Q4 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.